Kahn Medical Will Change The Color Of The Eyes Presenting At Medtech Insights Conference In San Francisco.Business Editors/Health/Medical Writers Medtech Insight 2004 In3 San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden Conference SAN FRANCISCO--(BUSINESS WIRE)--May 12, 2004 The company with the technology to "change" the color of the eyes has been invited to present at Medtech's "Invest In Innovation" event. Kahn Medical Devices is scheduled to present on Wednesday June 9th, 2004 at 11:20 AM. Kahn Medical Devices has developed an artificial iris diaphragm implant (NewIris)tm in light brown, light green or light blue, that is positioned into the eyes under topical anesthesia Topical Anesthesia Definition Topical anesthesia is a condition of temporary numbness caused by applying a substance directly to a surface of the body. Loss of feeling occurs in the specific areas touched by the anesthetic substance. through a controlled and safe ambulatory surgery ambulatory surgery n. Surgery performed on a person who is admitted to and discharged from a hospital on the same day. ambulatory surgery, n . Results are instant and amazingly natural. NewIris has been designed to stay into the eyes permanently although explanation is feasible. Patients appreciate that unlike cosmetic tinted contact lenses, no one can tell its not your natural iris color as depth and shine are preserved. Patients are able to continue with their lifestyles and even water activities. Delary Kahn, president of Kahn Medical, inventor and developer of the artificial iris diaphragm implant presented his experience after successfully implanting NewIris in a number of patients solely for cosmetic reasons at the X Keratomileusis keratomileusis /ker·a·to·mi·leu·sis/ (ker?ah-to-mi-loo´sis) keratoplasty in which a slice of the patient's cornea is removed, shaped to the desired curvature, and then sutured back on the remaining cornea to correct optical error. Study Group International Congress /Feb.04 (corneal corneal pertaining to the cornea. See also keratitis, keratopathy. corneal anomaly includes microcornea, coloboma, megalocornea, dermoid, congenital opacity. corneal black body see corneal sequestrum (below). , refractive refractive capacity to refract light. refractive error a difference between the focal length of the cornea and lens, and the length of the eye, resulting in myopia or hyperopia. and implants ophthalmic surgeons) (www.kmsg.org) through a surgical procedure he has called "cosmetic implant iridoplasty." This was the first report of such a surgery world wide. NewIris was originally developed to help patients suffering from oculocutaneous albinism albinism Absence of the pigment melanin in the eyes, skin, hair, scales, or feathers. It arises from a genetic defect and occurs in humans and other vertebrates. Because they lack the pigments that normally provide protective coloration and screen against the sun's (lack of pigment in eyes and skin) and colobomas (abnormal iris and pupils structure). These patients benefit from less glare and fotofobia having the implants. Albinos benefit also from having less U.V. radiation coming into the eyes. These are not very common conditions where NewIris can offer a somehow better quality of life, stated Kahn. Kahn Medical is based in Panama City at the International Technopark-City of Knowledge (www.cdspanama.org) a cluster of research institutions and universities oriented into the new global economy. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion